Effects of calcium salts of fatty acids and calcium salt of methionine hydroxy analogue on plasma prostaglandin F2alpha metabolite and milk fatty acid profiles in late lactation Holstein-Friesian cows.
Effects of a dietary lipid supplement containing calcium salts of fatty acids and methionine hydroxy analogue on plasma prostaglandin F2alpha (PGF2alpha) metabolite (PGFM) and milk fatty acid profiles were examined in 40 late lactation, nonpregnant, Holstein-Friesian cows for a period of 70 days. Effects on milk production, milk composition, and blood metabolites were also examined. Cows were paired on the basis of lactation number (first lactation, n = 8; second lactation, n = 32) and randomly assigned from within pairs to one of two dietary treatments: unsupplemented control (C) or 400 g per cow per day of the lipid supplement (S). Cows receiving the supplement had higher (P < 0.05) total milk production, total fat production (kg), and total lactose production (kg). Plasma cholesterol was significantly higher (P < 0.01) after 30 days of treatment in cows receiving the supplement. Cows receiving the supplement had lower (P < 0.01) concentrations of short chain milk fatty acids (C4:0 to C14:1) and higher concentrations of long chain fatty acids (C18:1 and C18:2; P < 0.01) than control animals. Oxytocin-induced prostaglandin release on Day 16 postovulation was increased (P < 0.01) in cows receiving the supplement. In conclusion, supplementation with calcium salts of fatty acids and methionine hydroxy analogue significantly increased milk yield and plasma PGFM.
Fahey
J
J
Teagasc, Dairy Production Research Department, Dairy Production Research Centre, Fermoy, Co. Cork, Ireland.
Mee
J F
JF
Murphy
J J
JJ
O'Callaghan
D
D
D000818:Animals; D001774:Blood Chemical Analysis / Q000662:veterinary; D002417:Cattle / Q000378:metabolism* / Q000502:physiology; D019587:Dietary Supplements; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000096:biosynthesis* / Q000097:blood / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism* / Q000494:pharmacology*; D005260:Female; D007774:Lactation; D019787:Linoleic Acid / Q000378:metabolism; D008715:Methionine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology*; D008892:Milk / Q000378:metabolism*; D008894:Milk Proteins / Q000378:metabolism; D010121:Oxytocin / Q000378:metabolism; D011897:Random Allocation
D005227:Fatty Acids; D008894:Milk Proteins; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D010121:Oxytocin; C008391:alpha-hydroxy-gamma-methylmercaptobutyric acid; D019787:Linoleic Acid; D008715:Methionine; D015237:Dinoprost